Companies /Healthcare

Merck & Co Inc

NYSE: MRK Drug Manufacturers - General
$151.01
▼ $2.09 (−1.36%) today
Markets open · 2:12pm ET

MRK Coverage

Page 71
1:38pm ET
Health and Healthcare

Long-Term Risks To Statin Sales? (MRK, PFE, AZN)

We have run a full feature story over at BioHealthInvestor.com after reading a study that came off the Mayo Clinic site.  The study showed that a combination of fish oil and red…

Douglas A. McIntyre
7:31am ET
Health and Healthcare

This Week’s BioHealth & Biotech Top Stories

We saw another exciting week full of news for key developments in drug stocks, biotech stocks, medical device stocks, and other companies involved in various aspects of health care and medicine.  Below…

Douglas A. McIntyre
4:01pm ET
Health and Healthcare

Amgen, Finally Some Good News (AMGN, MRK)

Shares of Amgen Inc. (NASDAQ: AMGN) are seeing a small gain in after-hours trading.  The troubled biotech giant announced that findings from its head-to-head, double-blind trial comparing the effects of denosumab in…

Douglas A. McIntyre
12:17pm ET
Health and Healthcare

Biotech Business Daily (GSK, MRK, OMPI, STEM, TEVA, VNDA)

Here are some of the top stories today that affecting key drug and biotech stocks: GlaxoSmithKline (NYSE: GSK) reorganized its corporate structure, increasing focus on emerging markets such as China, Russia, Brazil,…

Douglas A. McIntyre
5:49pm ET
Health and Healthcare

Merck’s (MRK) Hopes Crushed

Merck (MRK) had high hopes for its cholesterol drug Cordaptive According to The Wall Street Journal, things did not work out. The paper reports that the agency issuing a "not approvable" letter…

MRK
Douglas A. McIntyre